Shelun Tsai

Dr. Shelun Tsai

Ob/Gyn, Weill Cornell Medicine, New York, USA
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
LMLimor Man
Limor Man
NGNicole Lustgarten Guahmich
Nicole Lustgarten Guahmich
NVNina Vyas
Nina Vyas
STShelun Tsai
Shelun Tsai
LALaury Arazi
Laury Arazi
DJDaylon James
Daylon James
The ovarian reserve is finite and begins declining from its peak at mid-gestation until only residual follicles remain as women approach menopause. Reduced ovarian reserve, or its extreme form, premature ovarian insufficiency, stems from multiple factors, including developmental, genetic, environmental exposures, autoimmune disease, or medical/surgical treatment. In many cases, the cause remains unknown and resulting infertility is not ultimately addressed by assisted reproductive technologies. Deciphering the mechanisms that underlie disorders of ovarian reserve could improve the outcomes for patients struggling with infertility, but these disorders are diverse and can be categorized in multiple ways. In this review, we will explore the topic from a perspective that emphasizes the prevention or mitigation of ovarian damage. The most desirable mode of fertoprotection is primary prevention (intervening before ablative influence occurs), as identifying toxic influences and deciphering the mechanisms by which they exert their effect can reduce or eliminate exposure and damage. Secondary prevention in the form of screening is not recommended broadly. Nevertheless, in some instances where a known genetic background exists in discrete families, screening is advised. As part of prenatal care, screening panels include some genetic diseases that can lead to infertility or subfertility. In these patients, early diagnosis could enable fertility preservation or changes in family-building plans. Finally, Tertiary Prevention (managing disease post-diagnosis) is critical. Reduced ovarian reserve has a major influence on physiology beyond fertility, including delayed/absent puberty or premature menopause. In these instances, proper diagnosis and medical therapy can reduce adverse effects. Here, we elaborate on these modes of prevention as well as proposed mechanisms that underlie ovarian reserve disorders.

19 May 2021 in Medical Science Educator
Verified
Journal Article
Closed access
PDF file
STShelun Tsai
Shelun Tsai
MSMichael Sun
Michael Sun
MAMelinda L. Asbury
Melinda L. Asbury
JWJeremy M. Weber
Jeremy M. Weber
TTTracy Truong
Tracy Truong
EDElizabeth Deans
Elizabeth Deans

7 February 2022 in Journal of Assisted Reproduction and Genetics
Verified
Journal Article
Closed access
PDF file
STShelun Tsai
Shelun Tsai
TTTracy Truong
Tracy Truong
JEJennifer L. Eaton
Jennifer L. Eaton

17 January 2022 in Fertility and Sterility
Verified
Journal Article
Closed access
STShelun Tsai
Shelun Tsai
ECEsther H. Chung
Esther H. Chung
TTTracy Truong
Tracy Truong
AFAmanda S. Farrell
Amanda S. Farrell
JWJenny Wu
Jenny Wu
JEJennifer L. Eaton
Jennifer L. Eaton

11 August 2023 in Journal of Assisted Reproduction and Genetics
Verified
Journal Article
Closed access
PDF file
STShelun Tsai
Shelun Tsai
JJJasmyn Johal
Jasmyn Johal
JMJonas Malmsten
Jonas Malmsten
SSSteven Spandorfer
Steven Spandorfer

19 December 2022 in Journal of Assisted Reproduction and Genetics
Verified
Journal Article
Closed access
PDF file
STShelun Tsai
Shelun Tsai
JHJenna S. Hynes
Jenna S. Hynes
NZNicole Zanolli
Nicole Zanolli
DRDouglas Raburn
Douglas Raburn
ASAnne Z. Steiner
Anne Z. Steiner